NDC 0591-2127

Brinzolamide

Brinzolamide

Brinzolamide is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Brinzolamide.

Product ID0591-2127_02f829f4-fb18-423d-9918-4c5b35fa2762
NDC0591-2127
Product TypeHuman Prescription Drug
Proprietary NameBrinzolamide
Generic NameBrinzolamide
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-03-08
Marketing CategoryANDA /
Application NumberANDA209406
Labeler NameActavis Pharma, Inc.
Substance NameBRINZOLAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0591-2127-12

1 BOTTLE, PLASTIC in 1 CARTON (0591-2127-12) > 15 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2021-03-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Brinzolamide" or generic name "Brinzolamide"

NDCBrand NameGeneric Name
0591-2127BrinzolamideBrinzolamide
0781-6014BrinzolamideBrinzolamide
24208-464BRINZOLAMIDEbrinzolamide
63629-8793BrinzolamideBrinzolamide
68682-464BRINZOLAMIDEbrinzolamide
0065-0275Azoptbrinzolamide
0078-0722Azoptbrinzolamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.